国家和国际早产胎膜早破管理临床实践指南的系统综述
该系统综述检索2004年至2024年9月Medline、PubMed、Embase、Google Scholar及妇产科协会出版物,纳入17部国家或国际专业学会或政府机构发布的早产胎膜早破管理临床实践指南,用AGREE II评估质量。13部指南总体质量评分高。所有指南一致推荐24至34周使用预防性抗生素和产前糖皮质激素;8部推荐单用红霉素,6部承认最佳抗生素方案不确定。在晚期早产和存活前孕周使用产前糖皮质激素、重复疗程、存活前早产胎膜早破管理和分娩时机(尤其产前检出B族链球菌时)方面推荐存在差异。结论认为国际共识不足,需进一步研究。
要点
- 所有17部指南一致推荐24至34周妊娠使用预防性抗生素和产前糖皮质激素。
- 8部指南推荐单用红霉素,6部指南承认最佳抗生素方案尚不确定。
- 晚期早产和存活前孕周的产前糖皮质激素使用、重复疗程、存活前早产胎膜早破管理和分娩时机推荐存在差异。
核心结论
- 本综述显示国际指南对早产胎膜早破许多方面的最佳管理缺乏共识,在抗生素方案选择、晚期早产和存活前孕周的产前糖皮质激素使用及分娩时机等关键领域存在不一致。
- 需要进一步研究以填补这些知识空白,从而提供一致的指南并实施最佳实践照护。
研究设计与样本
- 系统综述,检索Medline、PubMed、Embase、Google Scholar及妇产科协会出版物,纳入2004年至2024年9月发表的指南。
- 纳入由国际专业医学学会或政府机构发布的早产胎膜早破管理临床实践指南。
- 由2名独立评审员完成筛选和数据提取,由3名评审员使用AGREE II工具进行质量评估。
- 共17部临床实践指南符合纳入标准并纳入综述。
主要发现
- 13部临床实践指南使用AGREE II标准获得高总体质量评分。
- 所有临床实践指南一致同意在24至34周妊娠使用预防性抗生素和产前糖皮质激素。
- 8部临床实践指南推荐单用红霉素,6部临床实践指南承认最佳抗生素方案不确定。
- 在晚期早产和存活前孕周使用产前糖皮质激素、产前糖皮质激素重复疗程、存活前早产胎膜早破的最佳管理及分娩时机(尤其产前检出B族链球菌时)方面推荐存在差异。
关键数值与推荐
- 所有17部指南一致推荐24至34周妊娠使用预防性抗生素和产前糖皮质激素。
- 8部指南推荐单用红霉素;6部指南承认最佳抗生素方案不确定。
- 13部指南AGREE II总体质量评分为高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Preterm prelabor rupture of membranes is a common pregnancy complication and a major contributor to preterm birth, but lacks contemporary evidence to guide management. This systematic review aims to highlight the areas of consensus and inconsistency between international guidelines. DATA SOURCES: Medline, PubMed, Embase, Google Scholar, and publications from obstetrics and gynecology societies were searched for guidelines published from 2004 until September 2024. STUDY ELIGIBILITY CRITERIA: Clinical practice guidelines addressing preterm prelabor rupture of membranes management published by an international professional medical society or government body were eligible for inclusion. METHODS: A comprehensive search was conducted, with screening and data abstraction completed by 2 independent reviewers. Quality assessment was performed by 3 reviewers using the AGREE II (Appraisal of Guidelines for Research and Evaluation II) instrument. RESULTS: A total of 17 clinical practice guidelines met the inclusion criteria and were included in the review. Thirteen clinical practice guidelines received a high overall quality score using the AGREE II criteria. All clinical practice guidelines agreed on the use of prophylactic antibiotics and antenatal corticosteroids between 24 and 34 weeks' gestation. Erythromycin alone was recommended by 8 clinical practice guidelines, and uncertainty about the optimal antibiotic regimen was acknowledged by 6 clinical practice guidelines. There was variation in recommendations on the use of antenatal corticosteroids in late preterm and previable gestations, the use of repeat courses of antenatal corticosteroids, the optimal management of previable preterm prelabor rupture of membranes, and timing of birth, especially when group B Streptococcus was detected antenatally. CONCLUSION: This review demonstrated a lack of international consensus on the optimal management of many aspects of preterm prelabor rupture of membranes, with inconsistencies identified in key areas such as selection of antibiotic regimens, use of antenatal corticosteroids in late preterm and previable gestations, and timing of birth. Further research is required to address these knowledge gaps in order to provide consistent guidelines and implement best-practice care.
引用
- Kua S, Roman A, Harbinson L, et al. Systematic review of national and international clinical practice guidelines for management of preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2025. PMID: 41285214. doi:10.1016/j.ajog.2025.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。